Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—
About
Access Biotechnology invests in transformative therapies for conditions with high unmet needs and that have the potential to meaningfully impact human health.
Portfolio
No portfolio companies in this dataset yet.
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Access Biotechnology's primary investment focus?
- Access Biotechnology invests in transformative therapies for conditions with high unmet needs, aiming to meaningfully impact human health.
- What type of investor is Access Biotechnology?
- Access Biotechnology is classified as a corporate venture capital (CVC) firm.
- Which sector does Access Biotechnology primarily invest in?
- Access Biotechnology's portfolio and investment rounds are concentrated in the Health Tech & Life Sciences sector.
- Can you name a notable company in Access Biotechnology's portfolio?
- A notable company in Access Biotechnology's portfolio is Upstream Bio, which has raised $400M and was founded in 2021.
- What was Access Biotechnology's first recorded investment date?
- Access Biotechnology's first recorded investment date was June 1, 2022.
- Has Access Biotechnology led any investment rounds?
- According to startupim data, Access Biotechnology has a lead investor share of 0%, indicating it has not led any investment rounds.
- What is the typical investment amount range for Access Biotechnology?
- Access Biotechnology's recorded investment range is $200M - $200M per round.
- In which funding stages has Access Biotechnology participated?
- Access Biotechnology has participated in A Round and B Round funding stages, with one investment in each stage.